Aktis Oncology

Aktis Oncology is a clinical-stage biotechnology company developing next-generation precision radiopharmaceuticals for the treatment of cancer. The company has built a proprietary miniprotein radioconjugate platform that pairs tumor-targeting miniproteins with targeted alpha-particle emitters, aiming to reach solid-tumor types that have been difficult to address with existing radiopharmaceutical therapies. Aktis focuses on patient populations with significant unmet medical need, advancing a pipeline of targeted alpha-based therapeutic candidates. The company operates from Boston, Massachusetts, with an additional site in Research Triangle Park, North Carolina. Aktis Oncology was surfaced as an a16z portfolio company and added to the API Evangelist network; it is a biotechnology company with no public developer API surface.

Aktis Oncology is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Oncology, and Radiopharmaceuticals.

Aktis Oncology’s developer surface includes support and 6 more developer resources.

🌐 Visit website 📡 Source on GitHub

14.6/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologyPharmaceuticalsOncologyRadiopharmaceuticalsPrecision MedicineHealthcareLife Sciences

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 14.6/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.9 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/aktis-oncology: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 3

The organization behind the API

Website

Website

LinkedIn

Investors

Investors

Source (apis.yml)

aid: aktis-oncology
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/aktis-oncology.png
name: Aktis Oncology
description: Aktis Oncology is a clinical-stage biotechnology company developing next-generation precision radiopharmaceuticals
  for the treatment of cancer. The company has built a proprietary miniprotein radioconjugate platform that pairs tumor-targeting
  miniproteins with targeted alpha-particle emitters, aiming to reach solid-tumor types that have been difficult to address
  with existing radiopharmaceutical therapies. Aktis focuses on patient populations with significant unmet medical need, advancing
  a pipeline of targeted alpha-based therapeutic candidates. The company operates from Boston, Massachusetts, with an additional
  site in Research Triangle Park, North Carolina. Aktis Oncology was surfaced as an a16z portfolio company and added to the
  API Evangelist network; it is a biotechnology company with no public developer API surface.
url: https://raw.githubusercontent.com/api-evangelist/aktis-oncology/refs/heads/main/apis.yml
x-type: company
x-source: a16z-portfolio
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Oncology
- Radiopharmaceuticals
- Precision Medicine
- Healthcare
- Life Sciences
apis: []
common:
- type: DomainSecurity
  url: security/aktis-oncology-domain-security.yml
- type: Website
  url: https://www.aktisoncology.com
  name: Aktis Oncology
- type: Support
  url: https://www.aktisoncology.com/contact-us/
  name: Contact Us
- type: PrivacyPolicy
  url: https://www.aktisoncology.com/privacy-policy/
  name: Privacy Policy
- type: TermsOfService
  url: https://www.aktisoncology.com/terms/
  name: Terms & Conditions
- type: LinkedIn
  url: https://www.linkedin.com/company/aktis-oncology
  name: LinkedIn
- type: Investors
  url: https://investors.aktisoncology.com/
  name: Investors
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence